Effect of BMPR-2 Gene Mutations on Hemodynamic Response by Iloprost Inhalation in Pulmonary Arterial Hypertension

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 25, 2018

Study Completion Date

December 25, 2018

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Iloprost

Iloprost inhalation, 2.5 - 5mcg, 6 times per day

Trial Locations (6)

Unknown

Soonchunhyang University Bucheon Hospital, Bucheon-si

Seoul National University Bundang Hospital, Seongnam

Catholic University Seoul Saint Mary's Hospital, Seoul

Seoul National University Hospital, Seoul

Sungkyunkwan University Seoul Samsung Hospital, Seoul

405-760

Gachon University Gil Hospital, Incheon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Seoul National University Hospital

OTHER

collaborator

Seoul National University Bundang Hospital

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Bayer

INDUSTRY

lead

Gachon University Gil Medical Center

OTHER